封面
市場調查報告書
商品編碼
1302891

乳糖酸市場 - 2023 年至 2028 年預測

Lactobionic Acid Market - Forecasts from 2023 to 2028

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球乳糖酸市場預計將從2021年的37.51億美元增長到2028年的53.52億美元,複合年增長率為5.21%。

二糖乳糖被氧化產生乳糖酸。它是一種半乳糖(一種糖)與 PHA 的葡萄糖酸內酯結合的分子。乳糖酸比 PHA 極性更強、體積更大,還具有作為強大抗氧化劑和鐵螯合劑的優勢。乳糖酸已成為一種多功能多羥基酸,在化學、食品、製藥、化妝品和食品領域具有許多有吸引力的應用。

主要市場驅動因素是乳糖素作為生物活性成分的廣泛應用,特別是在醫療領域、化妝品領域的巨大需求以及可生物降解產品的普及。乳糖酸在肉類和畜產品中的多種用途正在增加其在食品領域的需求。許多健康相關產品都含有乳糖酸,包括藥物、抗生素和器官捐贈中使用的靜脈輸液。

在移植醫學中,這種保存液被廣泛認為是器官灌注臨床溶解的金標準,因為它有助於在保存器官時防止自由基對組織造成損傷。此外,乳糖酸可以穩定含有敏感藥物成分的藥物製劑。作為碳水化合物結合蛋白的獨特高親和力抑製劑,乳糖酸有望促進針對疫苗刺激的乳腺腫瘤的免疫反應,從而導致腫瘤消退並提高生存率。添加乳糖酸的膳食補充劑可以幫助避免鈣缺乏。

製藥和健康行業正在推動對乳糖酸的需求。

藥品、抗生素和器官移植保存液只是經常使用乳糖酸的一些健康相關產品。此外,乳糖酸還可作為含有強效藥用成分的藥物製劑的穩定劑。尤其是乳糖酸,它是碳水化合物結合蛋白的高親和力抑製劑,可以增強疫苗刺激的針對乳腺癌的免疫反應,從而導致腫瘤消退並提高生存率。在營養補充劑中添加乳糖酸可預防因缺鈣引起的疾病。

人們對乳糖酸益處的認識不斷加深,正在影響化妝品行業的需求。

對於無法耐受深層去角質的嬌嫩皮膚類型,乳糖酸可以去除皮膚表層的角質。這種物質的抗氧化特性有助於讓您的皮膚煥發光彩,增強膚色和質感。根據一項研究,乳糖酸可以增強皮膚的脂質屏障,保護其免受其他環境的侵害,並防止其受到 V 損傷。乳糖酸因其能夠淡化皮膚變色和細紋而備受推崇。它也是許多化妝品中的重要成分,可為皮膚增添光澤和光澤。

預計在整個預測期內,北美仍將是領先的乳糖酸市場。

該地區的一大推動力是乳糖酸在化妝品中的新應用。北美消耗的大部分乳糖酸是從中國和歐洲運輸以滿足需求。乳糖酸最常用的用戶是該地區的醫療和製藥行業。在食品和飼料工業中,由於其多功能附加值,對這種有機酸的需求正在增加。在食品領域,自從美國食品和藥物管理局批准將其用作各種食品中的食品添加劑以來,需求顯著增加。

市場趨勢:

  • 2022年5月,Reliable Biopharmaceutical LLC增加了乳糖酸(LBA)的產能。這種增強使乳糖酸產量增加了 50%。
  • 今天,Sandoz INC.宣布將於2021年3月推出Amlactin (R)的新產品Rapid Relief Restoring Cream。這款新面霜的推出擴大了該品牌的保濕產品系列。含 15% 乳酸的 Amlactin Rapid Relief Restoring Cream 是一款日常保濕霜,可立即改善皮膚外觀。

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場細分
  • 貨幣
  • 先決條件
  • 基準年和預測年的時間表

第二章研究方法論

  • 調查數據
  • 調查過程

第三章執行摘要

  • 調查亮點

第四章市場動態

  • 市場驅動力
  • 市場製約因素
  • 波特五力分析
  • 行業價值鏈分析

5.全球乳糖酸市場,按應用

  • 介紹
  • 化妝品
  • 食物
  • 製藥/醫療
  • 其他

第六章全球乳糖酸市場:按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印度尼西亞
    • 泰國
    • 其他

第七章競爭環境及分析

  • 主要公司及戰略分析
  • 初創企業和市場盈利能力
  • 合併、收購、協議與合作
  • 供應商競爭力矩陣

第八章公司簡介

  • Sandoz INC.
  • Bio-Sugars Technology Co. LTD
  • Merck Group(Sigma-Aldrich)
  • Reliable Biopharmaceutical LLC
  • Hangzhou Dayangchem Co.LTD.
  • Wuxi Sigma Chemical Products Co.LTD.
  • Cayman Chemical Company
  • Extrasynthese
簡介目錄
Product Code: KSI061615043

The global lactobionic acid market is expected to grow at a CAGR of 5.21% from US$3.751 billion in 2021 to US$5.352 billion in 2028.

The disaccharide lactose is oxidized to produce lactobionic acid. It is a molecule in which galactose, a sugar, is joined to the PHA gluconolactone. More polar and bulky than PHAs, lactobionic acid also has the advantages of being a potent antioxidant and an iron chelator. It has emerged as a versatile polyhydroxy acid with many intriguing uses in the chemical, food, pharmaceutical, cosmetic, and food sectors.

The main market drivers are the broad range of uses for lactobionic as a bioactive component, particularly in medicine, its enormous demand in cosmeceuticals, and the popularity of biodegradable goods. The variety of uses for lactobionic acid in meat and animal products has led to an increase in its demand in the food sector. Many health-related goods, including medications, antibiotics, and fluids used in organ donation, include lactobionic acid.

In transplantation medicine, this preservation solution has been widely accepted as the gold standard for clinical dissolution of organ perfusion because it helps prevent free radical damage to tissues while organs are preserved. Additionally, lactobionic acid can stabilize pharmaceutical formulations that include delicate medicinal components. Vaccine-stimulated immune responses against breast tumors are facilitated by lactobionic acid, a unique high-affinity inhibitor molecule of carbohydrate-binding proteins, which may result in tumor regression and increased survival rates. Dietary supplements with lactobionic acid added help to avoid calcium deficiencies.

Pharmaceutical and health industries are driving the demand for lactobionic acid.

Pharmaceuticals, antibiotics, and preservation solutions for organ transplantation are just a few of the health-related goods that frequently employ lactobionic acid. Additionally, lactobionic acid serves as a stabilizer for pharmaceutical preparations that include potent medicinal ingredients. Vaccine-stimulated immune responses against breast tumors are promoted by lactobionic acid, a particularly high-affinity inhibitor chemical of carbohydrate-binding proteins that may result in tumor regression and a better survival outcome. The diseases caused by calcium shortage are prevented by adding lactobionic acid to dietary supplements.

Growing knowledge of lactobionic acid's benefits impacts its demand from the cosmetics industry.

For delicate skin types that cannot tolerate deeper forms of exfoliation, lactobionic acid exfoliates the top superficial layers of the skin. The antioxidant properties of the substance give your skin a slight glow and aid in enhancing skin tone and texture. According to certain research, lactobionic acid can enhance the skin's lipid barrier to shield it from other environmental aggressors and protect against V damage. The substance is highly prized for its capacity to lighten skin discoloration and fine wrinkles. It is also vital to many cosmetics that help skin shine and add luster.

North America will remain the major lactobionic acid market throughout the forecast period.

A significant regional driver is the new uses for lactobionic acid in cosmetics. A large portion of the lactobionic acid consumed in North America is shipped from China and Europe to fulfill demand. The medical and pharmaceutical industries in the area use lactobionic acid most frequently. The food and feed industry's need for this organic acid has increased due to its multifunctional value addition. The food sector has seen a considerable demand increase since the USFDA approved its use as a food additive in various food products.

Market Developments:

  • In May 2022, Reliable Biopharmaceutical LLC increased its lactobionic acid (LBA) production capacity. Production of Lactobionic Acid has increased by 50% due to the expansion.
  • In March 2021, the launch of AmLactin®'s new Rapid Relief Restoring Cream was announced by Sandoz I c. today. The brand's moisturizing product collection has expanded with this new cream's introduction. AmLactin Rapid Relief Restoring Cream, which contains 15% lactic acid, is a daily moisturizer that immediately improves the look of the skin.

Market Segmentation:

By Application

  • Cosmetics
  • Food
  • Pharmaceutical and Medical applications
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL LACTOBIONIC ACID MARKET, BY APPLICATION

  • 5.1. Introduction
  • 5.2. Cosmetics
  • 5.3. Food
  • 5.4. Pharmaceutical and Medical
  • 5.5. Others

6. GLOBAL LACTOBIONIC ACID MARKET, BY GEOGRAPHY

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. United States
    • 6.2.2. Canada
    • 6.2.3. Mexico
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
    • 6.3.3. Others
  • 6.4. Europe
    • 6.4.1. United Kingdom
    • 6.4.2. Germany
    • 6.4.3. France
    • 6.4.4. Spain
    • 6.4.5. Others
  • 6.5. Middle East and Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. Israel
    • 6.5.4. Others
  • 6.6. Asia Pacific
    • 6.6.1. Japan
    • 6.6.2. China
    • 6.6.3. India
    • 6.6.4. South Korea
    • 6.6.5. Indonesia
    • 6.6.6. Thailand
    • 6.6.7. Others

7. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 7.1. Major Players and Strategy Analysis
  • 7.2. Emerging Players and Market Lucrativeness
  • 7.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 7.4. Vendor Competitiveness Matrix

8. COMPANY PROFILES

  • 8.1. Sandoz INC.
  • 8.2. Bio-Sugars Technology Co. LTD
  • 8.3. Merck Group (Sigma-Aldrich)
  • 8.4. Reliable Biopharmaceutical LLC
  • 8.5. Hangzhou Dayangchem Co.LTD.
  • 8.6. Wuxi Sigma Chemical Products Co.LTD.
  • 8.7. Cayman Chemical Company
  • 8.8. Extrasynthese